In this episode of DeviceTalks, recorded live at our DeviceTalks Boston event at Boston Scientific‘s (NYSE:BSX) corporate headquarters, we talk with CEO Mike Mahoney to discuss the company’s recent turnaround.
Mahoney, who joined the company in 2012 and took over as CEO in 2013, sat down with MassDevice.com Publisher Brian Johnson for an exclusive, inside look at how he set about reversing the company’s fortunes.
“The company had always been great, and we went through a downturn, and we are really on a great run that will be sustainable,” he told us. “I’m really happy for the employees who had been here for a long time, because they tell me that. They say it’s so great to be part of a company that’s winning again, that’s fast, that’s innovating. That’s what’s most fun for me. It sure feels good for me, but when you give somebody a thirty-year award, she gives you a big bear hug, that’s much better.
In this long ranging interview, Mahoney took us inside several of the decisions he’s made over the past 3 years in the corner office, as well as his vision for a sustained future.